Literature DB >> 20807984

Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura.

Flora Peyvandi, Roberta Palla, Luca A Lotta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20807984      PMCID： PMC2930942          DOI： 10.3324/haematol.2010.027169

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  41 in total

1.  Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Haifeng M Wu; Dezhi Shang; Erica Falls; Christopher G Skipwith; Spero R Cataland; Charles L Bennett; Hau C Kwaan
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

2.  Survival and relapse in patients with thrombotic thrombocytopenic purpura.

Authors:  Johanna A Kremer Hovinga; Sara K Vesely; Deirdra R Terrell; Bernhard Lämmle; James N George
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

3.  HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians.

Authors:  P Coppo; M Busson; A Veyradier; A Wynckel; P Poullin; E Azoulay; L Galicier; P Loiseau
Journal:  J Thromb Haemost       Date:  2010-02-06       Impact factor: 5.824

4.  Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.

Authors:  M Furlan; R Robles; M Solenthaler; M Wassmer; P Sandoz; B Lämmle
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

5.  Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13.

Authors:  C Hughes; J R McEwan; I Longair; S Hughes; H Cohen; S Machin; M Scully
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

6.  Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link.

Authors:  M Scully; J Brown; R Patel; V McDonald; C J Brown; S Machin
Journal:  J Thromb Haemost       Date:  2009-11-17       Impact factor: 5.824

Review 7.  ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura.

Authors:  Luca A Lotta; Isabella Garagiola; Roberta Palla; Andrea Cairo; Flora Peyvandi
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

8.  Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.

Authors:  Sheng-Yu Jin; Christopher G Skipwith; X Long Zheng
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113

9.  IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  S Ferrari; G C Mudde; M Rieger; A Veyradier; J A Kremer Hovinga; F Scheiflinger
Journal:  J Thromb Haemost       Date:  2009-08-11       Impact factor: 5.824

10.  ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.

Authors:  Flora Peyvandi; Silvia Lavoretano; Roberta Palla; Hendrik B Feys; Karen Vanhoorelbeke; Tullia Battaglioli; Carla Valsecchi; Maria Teresa Canciani; Fabrizio Fabris; Samo Zver; Marienn Réti; Danijela Mikovic; Mehran Karimi; Gaetano Giuffrida; Luca Laurenti; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2008-01-26       Impact factor: 9.941
View more
  3 in total

1.  Thrombotic thrombocytopenic purpura in a new onset lupus patient?

Authors:  Nery Sablón González; Noel Lorenzo; Yanet Parodis; Maria Belen Alonso Ortiz; Melek Kechida; Jose Carlos Rodriguez Perez
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

2.  Unmet needs in the management of immune-mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK-A modified-Delphi study.

Authors:  Marie Scully; Tina Dutt; Will Lester; Emily Farrington; Stevie Lockwood; Richard Perry; Steve Holmes
Journal:  EJHaem       Date:  2022-04-28

3.  Heparin-Related Thrombocytopenia Triggered by Severe Status of Systemic Lupus Erythematosus and Bacterial Infection.

Authors:  Satoshi Suzuki; Shihoko Nakajima; Taiki Ando; Keisuke Oda; Manabu Sugita; Kunimi Maeda; Yutaka Nakiri; Yoshinari Takasaki
Journal:  Case Rep Rheumatol       Date:  2016-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.